Friday, April 25, 2014

UCLA Whistle-blower Suit: Does Industry Money Corrupt Academic Medicine?

›
According to the story in the L.A. Times : http://www.latimes.com/business/la-fi-ucla-doctor-conflicts-20140423,0,3924175.story#axzz2zwLITY...
1 comment:
Friday, April 18, 2014

“Breakthrough Cures”? Reasons for Skepticism

›
Earlier this week I posted about the current issue of the New England Journal , and mentioned in passing the appearance of antiviral drugs...
1 comment:

The History of US Drug Policy Since the Cold War

›
One theme in HOOKED is the need to see today’s relationship between the medical profession and the pharmaceutical industry in proper histo...
1 comment:
Thursday, April 17, 2014

Yet More on Statins and the Recent Guidelines

›
Not to make this blog the “Statins Blog” or anything, but since I have been on a tear regarding the unfortunate ACC/AHA guidelines on chol...

Summarizing the “Market Failure” Special Issue of the New England Journal

›
Three articles in this week’s New England Journal of Medicine all combine to illustrate “market failure” in the pharmaceutical industry. ...
Thursday, April 10, 2014

More on Flu Drugs and the Broken Drug Research System

›
We’ve discussed the debate over oseltamivir (Tamiflu) and the problems in determining whether it offers advantages to flu patients, give...
2 comments:
Tuesday, April 8, 2014

AMC Leaders on Corporate Boards—A Modest Proposal

›
Dr. Roy Poses over at Health Care Renewal has for some time been speaking out about conflicts of interest posed by leaders of academic med...